0 false false false false false false false false false true false false false false false false No description of principal activity 2022-06-16 Sage Accounts Production Advanced 2021 - FRS102_2021 2,399 2,399 600 600 1,799 xbrli:pure xbrli:shares iso4217:GBP 14177528 2022-06-16 2023-06-30 14177528 2023-06-30 14177528 bus:Director1 2022-06-16 2023-06-30 14177528 bus:Director2 2022-06-16 2023-06-30 14177528 core:WithinOneYear 2023-06-30 14177528 core:ShareCapital 2023-06-30 14177528 core:RetainedEarningsAccumulatedLosses 2023-06-30 14177528 bus:Director1 2023-06-30 14177528 bus:SmallEntities 2022-06-16 2023-06-30 14177528 bus:AuditExemptWithAccountantsReport 2022-06-16 2023-06-30 14177528 bus:FullAccounts 2022-06-16 2023-06-30 14177528 bus:SmallCompaniesRegimeForAccounts 2022-06-16 2023-06-30 14177528 bus:PrivateLimitedCompanyLtd 2022-06-16 2023-06-30 14177528 core:ComputerEquipment 2022-06-16 2023-06-30 14177528 core:ComputerEquipment 2023-06-30
COMPANY REGISTRATION NUMBER: 14177528
Strategic Health and Performance Limited
Filleted Unaudited Financial Statements
30 June 2023
Strategic Health and Performance Limited
Statement of Financial Position
30 June 2023
30 Jun 23
Note
£
£
Fixed assets
Tangible assets
4
1,799
Current assets
Cash at bank and in hand
975
Creditors: amounts falling due within one year
5
6,481
-------
Net current liabilities
5,506
-------
Total assets less current liabilities
( 3,707)
-------
Net liabilities
( 3,707)
-------
Capital and reserves
Called up share capital
1
Profit and loss account
( 3,708)
-------
Shareholders deficit
( 3,707)
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the Period ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 2 October 2023 , and are signed on behalf of the board by:
Mr D J Crumback
Mrs J L Crumback-Nyahoe
Director
Director
Company registration number: 14177528
Strategic Health and Performance Limited
Notes to the Financial Statements
Period from 16 June 2022 to 30 June 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Old St. Johns Church, Gamblesby, Penrith, Cumbria, CA101HR, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company has negative reserves of £3,708, the shareholders have agreed to continue to support the company for a minimum of 12 months from the date of signing the statement of financial position.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
25% straight line
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Tangible assets
Equipment
£
Cost
At 16 June 2022
Additions
2,399
-------
At 30 June 2023
2,399
-------
Depreciation
At 16 June 2022
Charge for the period
600
-------
At 30 June 2023
600
-------
Carrying amount
At 30 June 2023
1,799
-------
5. Creditors: amounts falling due within one year
30 Jun 23
£
Other creditors
6,481
-------
6. Directors' advances, credits and guarantees
During the Period the directors entered into the following advances and credits with the company:
30 Jun 23
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Mr D J Crumback
( 4,417)
( 4,417)
----
-------
-------